AI주식인사이트AI Stock Insight
D

아스타

246720KOSDAQ의료용품 및 기타 의약 관련제품 제조업

38.0 / 100

Reference Date: 2026-06-10

Financial Score7.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Roughly flat over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Asta is a technology-driven company established in 2006, specializing in the development, production, and sale of MALDI-TOF mass spectrometers and related consumables. The company has expanded into medical microbiology diagnostics and industrial applications, launching high-resolution LDI-TOF imaging systems and semiconductor process inspection tools like GM-TOF in 2024. It is also focusing on global market expansion through cloud-based diagnostic platforms and technology licensing.

Number of Employees

38people

Average Salary

65.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 19.194.0Point
PBR
10.78Industry Average 1.300.0Point

8.3x industry avg (risky)

ROE
-49.41Industry Average -4.893.5Point

10.1x industry avg (excellent)

Debt Ratio
29.87Industry Average 6.860.0Point

4.4x industry avg (risky)

Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼7.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼6.0% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -62.1% (improving, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 6,070Won52-week high 10,98052-week low 4,015
1-month return3.0Point

1m 0% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral주요사항보고서(중요한자산양수도결정(기타))2026-05-19
  • Neutral분기보고서 (2026.03)2026-05-15